Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized studyShishu Zhu, Pan Zhao, Fuchuan Wang et al.|Journal of Hepatology|2018Cited by 85
Long‐term benefits of interferon‐α therapy in children with HBeAg‐positive immune‐active chronic hepatitis BLimin Wang, Fu‐Sheng Wang, Jiaye Liu et al.|Journal of Viral Hepatitis|2021Cited by 21
Assessment of liver fibrosis by transient elastography in young children with chronic hepatitis B virus infectionZhi‐Qiang Xu, Jianguo Yan, Pu Wang et al.|Hepatology International|2021Cited by 19
Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1–5 years with iatrogenic chronic hepatitis CShishu Zhu, Fu‐Sheng Wang, Qing‐Lei Zeng et al.|Hepatology International|2015Cited by 9
IL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis CYanwei Zhong, Min Zhang, Hongfei Zhang et al.|International Journal of Biological Sciences|2016Cited by 7